These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 36701146)

  • 1. Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer.
    Cheng E; Shi Q; Shields AF; Nixon AB; Shergill AP; Ma C; Guthrie KA; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi SS; Ng K; O'Reilly EM; Brown JC; Philip PA; Caan BJ; Cespedes Feliciano EM; Meyerhardt JA
    JAMA Oncol; 2023 Mar; 9(3):404-413. PubMed ID: 36701146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Celecoxib vs Placebo Added to Standard Adjuvant Therapy on Disease-Free Survival Among Patients With Stage III Colon Cancer: The CALGB/SWOG 80702 (Alliance) Randomized Clinical Trial.
    Meyerhardt JA; Shi Q; Fuchs CS; Meyer J; Niedzwiecki D; Zemla T; Kumthekar P; Guthrie KA; Couture F; Kuebler P; Bendell JC; Kumar P; Lewis D; Tan B; Bertagnolli M; Grothey A; Hochster HS; Goldberg RM; Venook A; Blanke C; O'Reilly EM; Shields AF
    JAMA; 2021 Apr; 325(13):1277-1286. PubMed ID: 33821899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Survival With Adherence to the American Cancer Society Nutrition and Physical Activity Guidelines for Cancer Survivors After Colon Cancer Diagnosis: The CALGB 89803/Alliance Trial.
    Van Blarigan EL; Fuchs CS; Niedzwiecki D; Zhang S; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Giovannucci EL; Ng K; Meyerhardt JA
    JAMA Oncol; 2018 Jun; 4(6):783-790. PubMed ID: 29710284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials.
    Sinicrope FA; Shi Q; Allegra CJ; Smyrk TC; Thibodeau SN; Goldberg RM; Meyers JP; Pogue-Geile KL; Yothers G; Sargent DJ; Alberts SR
    JAMA Oncol; 2017 Apr; 3(4):472-480. PubMed ID: 28006055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
    Meyerhardt JA; Niedzwiecki D; Hollis D; Saltz LB; Hu FB; Mayer RJ; Nelson H; Whittom R; Hantel A; Thomas J; Fuchs CS
    JAMA; 2007 Aug; 298(7):754-64. PubMed ID: 17699009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
    Meyerhardt JA; Sato K; Niedzwiecki D; Ye C; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Wigler DS; Venook A; Fuchs CS
    J Natl Cancer Inst; 2012 Nov; 104(22):1702-11. PubMed ID: 23136358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations Between Unprocessed Red Meat and Processed Meat With Risk of Recurrence and Mortality in Patients With Stage III Colon Cancer.
    Van Blarigan EL; Ou FS; Bainter TM; Fuchs CS; Niedzwiecki D; Zhang S; Saltz LB; Mayer RJ; Hantel A; Benson AB; Atienza D; Messino M; Kindler HL; Venook AP; Ogino S; Sanoff HK; Giovannucci EL; Ng K; Meyerhardt JA
    JAMA Netw Open; 2022 Feb; 5(2):e220145. PubMed ID: 35191970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating Tumor DNA Analyses as Markers of Recurrence Risk and Benefit of Adjuvant Therapy for Stage III Colon Cancer.
    Tie J; Cohen JD; Wang Y; Christie M; Simons K; Lee M; Wong R; Kosmider S; Ananda S; McKendrick J; Lee B; Cho JH; Faragher I; Jones IT; Ptak J; Schaeffer MJ; Silliman N; Dobbyn L; Li L; Tomasetti C; Papadopoulos N; Kinzler KW; Vogelstein B; Gibbs P
    JAMA Oncol; 2019 Dec; 5(12):1710-1717. PubMed ID: 31621801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance).
    Fuchs MA; Yuan C; Sato K; Niedzwiecki D; Ye X; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Innocenti F; Warren RS; Bertagnolli MM; Ogino S; Giovannucci EL; Horvath E; Meyerhardt JA; Ng K
    Ann Oncol; 2017 Jun; 28(6):1359-1367. PubMed ID: 28327908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between the adapted dietary inflammatory index and colorectal cancer recurrence and all-cause mortality.
    Wesselink E; Staritsky LE; van Zutphen M; Geijsen AJMR; Kok DE; Kruyt F; Veenstra RP; Spillenaar Bilgen EJ; Kouwenhoven EA; de Wilt JHW; Kampman E; van Duijnhoven FJB
    Clin Nutr; 2021 Jun; 40(6):4436-4443. PubMed ID: 33478795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sleep and cancer recurrence and survival in patients with resected Stage III colon cancer: findings from CALGB/SWOG 80702 (Alliance).
    Lee S; Ma C; Shi Q; Meyers J; Kumar P; Couture F; Kuebler P; Krishnamurthi S; Lewis D; Tan B; O'Reilly EM; Shields AF; Meyerhardt JA
    Br J Cancer; 2023 Aug; 129(2):283-290. PubMed ID: 37179438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials.
    André T; Meyerhardt J; Iveson T; Sobrero A; Yoshino T; Souglakos I; Grothey A; Niedzwiecki D; Saunders M; Labianca R; Yamanaka T; Boukovinas I; Vernerey D; Meyers J; Harkin A; Torri V; Oki E; Georgoulias V; Taieb J; Shields A; Shi Q
    Lancet Oncol; 2020 Dec; 21(12):1620-1629. PubMed ID: 33271092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance).
    Morales-Oyarvide V; Yuan C; Babic A; Zhang S; Niedzwiecki D; Brand-Miller JC; Sampson-Kent L; Ye X; Li Y; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Ogino S; Wu K; Willett WC; Giovannucci EL; Wolpin BM; Meyerhardt JA; Fuchs CS; Ng K
    J Natl Cancer Inst; 2019 Feb; 111(2):170-179. PubMed ID: 30726946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Deficient DNA Mismatch Repair Status in Patients With Stage III Colon Cancer Treated With FOLFOX Adjuvant Chemotherapy: A Pooled Analysis From 2 Randomized Clinical Trials.
    Zaanan A; Shi Q; Taieb J; Alberts SR; Meyers JP; Smyrk TC; Julie C; Zawadi A; Tabernero J; Mini E; Goldberg RM; Folprecht G; Van Laethem JL; Le Malicot K; Sargent DJ; Laurent-Puig P; Sinicrope FA
    JAMA Oncol; 2018 Mar; 4(3):379-383. PubMed ID: 28983557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body Composition, Inflammation, and 5-Year Outcomes in Colon Cancer.
    Fleming CA; O'Connell EP; Kavanagh RG; O'Leary DP; Twomey M; Corrigan MA; Wang JH; Maher MM; O'Connor OJ; Redmond HP
    JAMA Netw Open; 2021 Aug; 4(8):e2115274. PubMed ID: 34459908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance).
    Lee S; Zhang S; Ma C; Ou FS; Wolfe EG; Ogino S; Niedzwiecki D; Saltz LB; Mayer RJ; Mowat RB; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Venook A; Gross CP; Irwin ML; Meyerhardt JA; Fuchs CS
    JNCI Cancer Spectr; 2021 Jun; 5(3):. PubMed ID: 34104867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma 25-Hydroxyvitamin D Levels and Survival in Stage III Colon Cancer: Findings from CALGB/SWOG 80702 (Alliance).
    Wang QL; Ma C; Yuan C; Shi Q; Wolpin BM; Zhang Y; Fuchs CS; Meyer J; Zemla T; Cheng E; Kumthekar P; Guthrie KA; Couture F; Kuebler P; Kumar P; Tan B; Krishnamurthi S; Goldberg RM; Venook A; Blanke C; Shields AF; O'Reilly EM; Meyerhardt JA; Ng K
    Clin Cancer Res; 2023 Jul; 29(14):2621-2630. PubMed ID: 37289007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diet- and Lifestyle-Based Prediction Models to Estimate Cancer Recurrence and Death in Patients With Stage III Colon Cancer (CALGB 89803/Alliance).
    Cheng E; Ou FS; Ma C; Spiegelman D; Zhang S; Zhou X; Bainter TM; Saltz LB; Niedzwiecki D; Mayer RJ; Whittom R; Hantel A; Benson A; Atienza D; Messino M; Kindler H; Giovannucci EL; Van Blarigan EL; Brown JC; Ng K; Gross CP; Meyerhardt JA; Fuchs CS
    J Clin Oncol; 2022 Mar; 40(7):740-751. PubMed ID: 34995084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Duration and Effects of 3 vs 6 Months of Adjuvant Chemotherapy in High-Risk Stage II Colorectal Cancer: A Subgroup Analysis of the TOSCA Randomized Clinical Trial.
    Petrelli F; Labianca R; Zaniboni A; Lonardi S; Galli F; Rulli E; Rosati G; Corallo S; Ronzoni M; Cardellino GG; Mattioli R; Mambrini A; Ciuffreda L; Banzi M; Pusceddu V; Maiello E; Zampino M; Zagonel V; Marchetti P; Corsi D; Rimassa L; Cinieri S; Sobrero A
    JAMA Oncol; 2020 Apr; 6(4):547-551. PubMed ID: 32053133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.